Cronos Group Inc.
CRON Healthcare Drug Manufacturers Specialty & Generic
Cronos Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.6 million, up 24.6% from fiscal 2024. In the quarter to June 2026, revenue grew 58.4%, EPS grew 190.0%, free cash flow grew 2,279.2% and total debt fell 4.71%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow CRON
Cronos Group Inc. (CRON) P/E ratio
As of 16 October 2026, Cronos Group Inc. (CRON) trades at a P/E ratio of 16.1×. Over the past ten years it has ranged from 0.0× (March 2026) to 1,001× (March 2018); the current reading is higher than 77% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 19.5× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 1.9× | — |
| FY2018 | 0.0× | — |
| FY2017 | 770× | 0.00% |
| FY2016 | 770× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 13.9× | (94.46%) |
| Mar 2026 | 251× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 27.8× | (27.23%) |
| 34 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| XERS Xeris Biopharma Holdings, Inc. compare | n/m |
| HROW Harrow, Inc. compare | n/m |
| AMPH Amphastar Pharmaceuticals, Inc. compare | 14.9× |
| ANIP ANI Pharmaceuticals, Inc. compare | 14.9× |
| COLL Collegium Pharmaceutical, Inc. compare | 15.2× |
| PAHC Phibro Animal Health Corporation compare | 15.8× |
| CRON Cronos Group Inc. | 16.1× |
| PCRX Pacira BioSciences, Inc. compare | 104× |
| ETON Eton Pharmaceuticals, Inc. compare | 107× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)